This week’s #BCTECH Summit commenced with several noteworthy announcements for the BC tech sector. The government has moved a long way towards the things we believe will be important to growing our sector, ensuring a strong pipeline of talent and bolstering the provincial economy.  Many of the announcements in the government’s update to the #BCTECH Strategy are aligned with recommendations…
Read More
As the U.S. border tightens for both political and bureaucratic reasons, the federal government is launching a new stream of its temporary foreign worker program to entice highly skilled workers to come to Canada. The program’s new “Global Talent” pilot stream was announced Thursday morning in Toronto by Navdeep Bains, Minister of Innovation, Science, and Economic Development, and Patty Hajdu,…
Read More
A new study at the University of British Columbia has produced a “definitive debunking” of a controversial procedure that surgically widens neck veins as a treatment for multiple sclerosis. Dr. Anthony Traboulsee has released the results of a $5.5-million clinical trial he believes will deliver the final death blow to so-called liberation therapy. For years, MS patients have been travelling around…
Read More
A private biotechnology company developing state-of-the-art lipid nanoparticle (LNP) delivery technology for messenger RNA (mRNA), announced today publication of data demonstrating that mRNA encoding a broadly neutralizing antibody delivered in an Acuitas LNP carrier protects humanized mice from HIV-1 challenge. In a paper published today in Nature Communications, Acuitas’ scientists and academic researchers lead by Drew Weissman, MD, PhD, a professor…
Read More
B.C.’s innovation-driven biotech leaders are stepping on to the world stage and generating $14.4 billion a year in economic effect in the process. Vancouver-based Stemcell Technologies, for example, has emerged as a global presence with customer support and distribution hubs in Canada, the United States, Europe, Asia and Australia, and annual revenues reportedly topping $150 million. But as impressive as that figure sounds — and…
Read More
Scientists at the University of B.C.have built a better mouse — one that is indifferent to cocaine. Unlike normal mice, the genetically engineered rodents did not show addictive behaviour even after repeated injections over days, suggesting that habitual drug use in humans may be a matter of genetics. While the finding is unlikely to yield a pill that cures addiction…
Read More

Quirks and Quarks of Vancouver Biotech

Quark Venture, a venture capital (VC) fund launched in 2016, has followed through with its promise of investing in prominent Vancouver biotech companies. The US$500 million fund, the largest of its kind in Canada, is expected to have a significant impact in the biotech industry both locally and nationwide. With over two thirds of research funding at the University of…
Read More